Tranexamic acid for preventing postpartum haemorrhage

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Novikova, Natalia ^a   Hofmeyr, G Justus ^b  

^a East London Hospital Complex   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRANEXAMIC ACID; UTEROTONIC AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; HUMAN; MATERNAL MORTALITY; POSTPARTUM HEMORRHAGE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; BLURRED VISION; DIARRHEA; GASTROINTESTINAL SYMPTOM; HYPOTENSION; KIDNEY CORTEX NECROSIS; LABOR STAGE; LABOR STAGE 3; NAUSEA; OUTCOME ASSESSMENT; RETINA ARTERY OCCLUSION; SYSTEMATIC REVIEW; THROMBOEMBOLISM; THROMBOSIS; UTERINE ATONY; VOMITING;

EID: 70049090989     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007872     Document Type: Review

References (21)

1. Astedt B. Clinical pharmacology of tranexamic acid. Scandinavian Journal of Gastroenterology 1987;137:22-25
2. Bekassy Z, Astedt B. Treatment with the fibrinolytic inhibitor tranexamic acid-risk for thrombosis?. Acta Obstetricia et Gynecologica Scandinavica 1990;69(4):353-354
3. Boylan JF, Klinck JR, Sandler AN, Arellano R, Greig PD, Nierenberg H, et al. Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 1996;85(5):1043-1048 (Pubitemid 26378289)
4. Pattinson RC. Saving mothers. Third Report on Confidential Enquiries into Maternal Deaths in South Africa 2002-2004. Pretoria, South Africa: Department of Health, 2006.
5. Cotter AM, Ness A, Tolosa JE. Prophylactic oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD001808]
6. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001.
7. Gates S. Methodological Guidelines. In: The Editorial Team. Pregnancy and Childbirth Group. About the Cochrane Collaboration (Collaborative Review Groups (CRGs)) 2005, Issue 2.
8. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochranehandbook.org.
9. Johansson T, Pettersson L, Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money. Acta Orthopaedica 2005;76(3):314-319
10. Jurema M, Zacur HA. Menorrhagia. http://www.uptodate.com/patients/ content/topic.do?topicKey=wom-issu/4769&title=Menstrual+cycle. 16.3. Uptodate, (accessed 2008).
11. Karski JM, Teasdale SJ, Norman P, Carroll J, VanKessel K, Wong P, et al. Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial. Journal of Thoracic and Cardiovascular Surgery 1995;110(3):835-842
12. Katsaros D, Petricevic M, Snow NJ, Woodhall DD, Van Bergen R. Tranexamic acid reduces postbypass blood use: a double-blinded, prospective, randomized study of 210 patients. Annals of Thoracic Surgery 1996;61(4):1131-1135 (Pubitemid 126336054)
13. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2000, Issue 4. [DOI: 10.1002/14651858.CD000249]
14. Longstaff C. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagulation & Fibrinolysis 1994;5(4):537-542 (Pubitemid 24301574)
15. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD003249.pub2]
16. Prendiville WJP, Elbourne D, McDonald SJ. Active versus expectant management in the third stage of labour. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD000007]
17. Reid RW, Zimmerman AA, Laussen PC, Mayer JE, Gorlin JB, Burrows FA. The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesthesia & Analgesia 1997;84(5):990-996
18. The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
19. Ronsmans C, Graham WJ. Maternal mortality: who, when, where, and why. Lancet 2006;368(9542):1189-1200 (Pubitemid 44441554)
20. Vacharaksa K, Prakanrattana U, Suksompong S, Chumpathong S. Tranexamic acid as ameans of reducing the need for blood and blood component therapy in children undergoing open heart surgery for congenital cyanotic heart disease. Journal of the Medical Association of Thailand 2002;85(Suppl 3):904-909 (Pubitemid 36025031)
21. Welsh A, McLintock C, Gatt S, Somerset D, Popham P, Ogle R. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Australian and New Zealand Journal of Obstetrics and Gynaecology 2008;48(1):12-16 (Pubitemid 351239149)